Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124260163 | 12426016 | 3 | F | 20130808 | 20160701 | 20160601 | 20160711 | EXP | AR-BIOGEN-2013BI078169 | BIOGEN | 53.84 | YR | F | Y | 0.00000 | 20160711 | MD | AR | AR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124260163 | 12426016 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | U | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | ||||||
124260163 | 12426016 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | U | 103628 | 30 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk | ||||||
124260163 | 12426016 | 3 | C | Hesperidin-diosmin | 2 | Unknown | 0 | UNKNOWN | |||||||||||
124260163 | 12426016 | 4 | C | CICLOPIROX. | CICLOPIROX | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124260163 | 12426016 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124260163 | 12426016 | 6 | C | PHENYTOIN. | PHENYTOIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124260163 | 12426016 | 7 | C | SIMETHICONE (DIMETHICONE) | DIMETHICONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124260163 | 12426016 | 8 | C | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124260163 | 12426016 | 9 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124260163 | 12426016 | 1 | Multiple sclerosis |
124260163 | 12426016 | 3 | Product used for unknown indication |
124260163 | 12426016 | 4 | Product used for unknown indication |
124260163 | 12426016 | 5 | Product used for unknown indication |
124260163 | 12426016 | 6 | Product used for unknown indication |
124260163 | 12426016 | 7 | Product used for unknown indication |
124260163 | 12426016 | 8 | Product used for unknown indication |
124260163 | 12426016 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124260163 | 12426016 | OT |
124260163 | 12426016 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124260163 | 12426016 | Abnormal behaviour | |
124260163 | 12426016 | Affective disorder | |
124260163 | 12426016 | Gait disturbance | |
124260163 | 12426016 | Memory impairment | |
124260163 | 12426016 | Petit mal epilepsy | |
124260163 | 12426016 | Syncope | |
124260163 | 12426016 | Thermal burn | |
124260163 | 12426016 | Treatment noncompliance |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124260163 | 12426016 | 1 | 20120203 | 201401 | 0 | |
124260163 | 12426016 | 2 | 201402 | 201603 | 0 |